A treatment for advanced melanoma that's newly approved by the FDA is giving cancer patients new hope. Tumor-infiltrating lymphocyte, or "TIL" therapy, uses an individual's own tumor to help fight the disease.
Home - CBSNews.com reports that a treatment for advanced melanoma that's newly approved by the FDA is giving cancer patients new hope.
The report adds: Tumor-infiltrating lymphocyte, or "TIL" therapy, uses an individual's own tumor to help fight the disease.
This report is covered across the current DAMMNEWS feeds. Health reports can affect personal decisions, so the source, study size and official guidance matter more than a short headline alone.
This is a developing report. DAMMNEWS will surface related coverage as closely matched reporting enters the live cache.
DAMMNEWS RSS BRIEFING — generated locally from the available Home - CBSNews.com headline and RSS excerpt. It is not a summary of the full source article.